Global HIV rates drop 20 but challenges persist in ending AIDS by 2030 Explore breakthroughs like lenacapavir prevention ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves. But ...

People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.

Biannual vaccinations with the drug lenacapavir offers effective protection against HIV infection, according to phase-3 study ...

The Phase III Purpose 2 trial compared the safety and efficacy of twice-yearly subcutaneous lenacapavir for pre-exposure ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

Gilead (GILD) announced The New England Journal of Medicine, or NEJM, published the full results from the company’s pivotal Phase 3 PURPOSE 2 ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Once inside the body, HIV persists because of its remarkable ability to hide within healthy CD4 T cells, where it can lie ...

Lead PURPOSE researcher Moupali Das, Vice President, Clinical Development, HIV Prevention & Pediatrics, designed the PURPOSE ...